about
Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors.New tools for carbohydrate sulfation analysis: heparan sulfate 2--sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitorsIdentification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening dataNew tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitorsAn in silico screen and structural analysis identifies bacterial kinase inhibitors which act with β-lactams to inhibit mycobacterial growthCovalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in ChordomaQuinazoline-Based Antivirulence Compounds Selectively Target Salmonella PhoP/PhoQ Signal Transduction SystemDesign and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity RelationshipsTowards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK)SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)Gram-scale synthesis of FICZ, a photoreactive endogenous ligand of the aryl hydrocarbon receptorNew Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I-Interacting Kinase (TNNi3K)CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancerRepurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative BacteriaCDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model
P50
Q47599671-AEE3E31A-2515-4B3C-97B2-59186504E307Q54978646-83D11600-5E07-423B-9541-45EA3FEF64FBQ56833662-69946EA5-0E3C-4114-A3FB-6C90A4FA06F3Q56889371-AF52677C-5628-4225-A50E-66605337D337Q56994432-8680F4D8-A535-41EB-B0B9-1DDDE2DEEC1AQ57029723-7CAA7A4C-16FA-49B9-BB4A-F04F6D053598Q60193666-15E98ADA-E077-4C9E-8502-3F2CEFFB367CQ64039562-B01F6141-6C12-417D-9A75-84F69B739CE4Q90701762-35269052-2919-4406-BCAF-CB91153CC28DQ91056516-9A5332D6-6B7F-4A75-9DFA-A9FF624E2329Q91168867-EAA2DE9C-03B3-474C-AF77-3CDA87E4CF24Q91616902-BFC3C858-A242-4A46-B416-28A3EF0E5526Q91776620-84177526-6B0C-4236-9A97-FDFB8C43068FQ91781246-90F1AECA-B099-4BAE-B848-BD2A84F7CB4BQ92525406-2E3B6FB1-E19E-4418-B619-C055B2F208E9Q92754419-172B6A6C-396B-4DA3-8DEF-B206D0A2D8B5Q94461416-D24271CC-78F7-449E-A972-A283D3E473FA
P50
description
researcher
@en
wetenschapper
@nl
name
William J Zuercher
@en
William J Zuercher
@nl
type
label
William J Zuercher
@en
William J Zuercher
@nl
prefLabel
William J Zuercher
@en
William J Zuercher
@nl
P31
P496
0000-0002-9836-0068